Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis prevalence in the United States commercially insured population.
BRIEF: Teva files for Copaxone-Laquinimod patent
Is the MS community ready to promote brain health? Reception and Symposium
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Optical Coherence Tomography in Multiple Sclerosis.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Zebrafish as a model to investigate CNS myelination.
Patient trial of immunization to treat Alzheimer’s disease begins at Cedars-Sinai
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?

Pages